TheraRadar

Pharma Intelligence, Simplified

← All Targets

RARɣ

2 drugs
Immunology
Market Leader
TAZORAC
ALMIRALL
2
approved indications
2
Approved Drugs
1
Companies
2
Indications
1
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (1 companies)
All 2 approved drugs
Therapeutic area breakdown
Full indication list (2 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

ALMIRALL 2 drugs

By Therapeutic Area

Immunology 2 drugs